CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab-Reference-Cited by-同舟云学术

CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab

Author:

Yan Min¹,Dong Zhaoming²,Zhao Frank¹,Chauncey Thomas²,Deauna-Limayo Delva³,Wang-Rodriguez Jessica¹,Liu Dayu⁴,Wang Huan-You¹,Pilz Renate¹

Affiliation:

1. Moores Cancer Center; University of California San Diego Health System; La Jolla CA USA

2. VA Puget Sound Health Care System; Seattle; WA USA

3. VA Hospital Southern Nevada; North Las Vegas NV USA

4. Qilu Hospital; Shandong University; Jinan China

Publisher

Wiley

Subject

Hematology,General Medicine

Link

Reference11 articles.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1);Mediterranean Journal of Hematology and Infectious Diseases;2024-01-01

5. Clinical Experience on Proteasome Inhibitors in Cancer;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15